Ember Therapeutics Garners $34,000,000 Series A Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dcb8a5d0-04c8-4d90-b854-ab75678a8112&Preview=1 -
Date
12/15/2011 -
Company Name
Ember Therapeutics -
Mailing Address
29 Newbury Street Boston, MA 02116 -
Company Description
Ember Therapeutics is a product-focused company translating its world-class biology in the emerging area of brown fat and recent breakthroughs in understanding the mechanisms of selective insulin sensitivity into a proprietary pipeline of peripherally-acting treatments for metabolic disease, including Type 2 diabetes and obesity. -
Website
http://www.embertx.com -
Transaction Type
Venture Equity -
Transaction Amount
$34,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Third Rock Ventures, LLC today announced the formation of Ember Therapeutics. The company was launched with a $34 million Series A financing. -
M&A Terms
-
Venture Investor
Third Rock Ventures
